Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients
Objective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and compare with current literature. Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men we...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ali İhsan Taşçı
2021-06-01
|
| Series: | Yeni Üroloji Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/1479046 |
| _version_ | 1797917474229846016 |
|---|---|
| author | Sercan Yilmaz Halil Cagri Aybal Hakan Ozdemir Eymen Gazel Engin Kaya Serdar Yalcin Mehmet Yilmaz Ali Yusuf Oner Mehmet Yorubulut Lutfi Tunc |
| author_facet | Sercan Yilmaz Halil Cagri Aybal Hakan Ozdemir Eymen Gazel Engin Kaya Serdar Yalcin Mehmet Yilmaz Ali Yusuf Oner Mehmet Yorubulut Lutfi Tunc |
| author_sort | Sercan Yilmaz |
| collection | DOAJ |
| description | Objective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and compare with current literature.
Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men were retrospectively analyzed. PI-RADS scores were determined as 3, 4 and 5 in 222 (62%), 107 (29.8%) and 29 (8.1%) patients, respectively. Totally 454 lesions were underwent MRI-US FPBx. 303 (66.7%) lesions were scored as PI-RADS 3, 120 (26.4%) lesions were scored as PI-RADS 4 and 31 (6.8%) lesions were scored as PI-RADS 5. 315 (69.3%) of lesions were in peripheral zone, 26 (5.7%) were in central zone, 111 (24.4%) were in transitional zone and 2 of them were in anterior fibromuscular stroma.
Results: Overall prostate cancer detection rate was 36.3%. Concerning detection rates, MRI-US FPBx alone and transrectal ultrasonography guided prostate biopsy (TRUS-Bx) alone were 27.6% and 26.5%, respectively. Cancer detection rate only through MRI-US FPBx PIRADS-3 and PI-RADS 4&5 were 6.9% and 20.6%, respectively. Clinically significant prostate cancer (csPCa) rates were evaluated and csPCa to overall prostate cancer (PCa) rates for TRUS-Bx, MRI-US FPBx and combined techniques were 16.8%, 35.4% and 39.2%, respectively. Results of 11 patients were evaluated as benign.
Conclusion: MRI-US FPBx significantly increases success rate of prostate biopsy procedure. Regarding current MRI technology, it is not appropriate to consider MRI-US FPBx as a stand-alone biopsy option without concomitant with TRUS-Bx. |
| first_indexed | 2024-04-10T13:14:07Z |
| format | Article |
| id | doaj.art-b310569000dc4a51af817017b10a1f8e |
| institution | Directory Open Access Journal |
| issn | 1305-2489 2687-1955 |
| language | English |
| last_indexed | 2024-04-10T13:14:07Z |
| publishDate | 2021-06-01 |
| publisher | Ali İhsan Taşçı |
| record_format | Article |
| series | Yeni Üroloji Dergisi |
| spelling | doaj.art-b310569000dc4a51af817017b10a1f8e2023-02-15T16:12:29ZengAli İhsan TaşçıYeni Üroloji Dergisi1305-24892687-19552021-06-0116214014710.33719/yud.2021;16-2-850577Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patientsSercan Yilmaz0https://orcid.org/0000-0001-6820-6708Halil Cagri Aybal1https://orcid.org/0000-0001-9123-6139Hakan Ozdemir2https://orcid.org/0000-0002-4458-3952Eymen Gazel3https://orcid.org/0000-0002-6483-9249Engin Kaya4https://orcid.org/0000-0002-5272-572XSerdar Yalcin5https://orcid.org/0000-0003-4586-7591Mehmet Yilmaz6https://orcid.org/0000-0003-3774-9982Ali Yusuf Oner7https://orcid.org/0000-0003-1123-6521Mehmet Yorubulut8https://orcid.org/0000-0003-1747-685XLutfi Tunc9https://orcid.org/0000-0002-7338-3909University of Health Sciences, Gulhane Training and Research Hospital, Department of Urology, Ankara, TurkeyKahramankazan Hamdi Eris State Hospital, Department of Urology, Ankara, TurkeyDiason Ultrasonography Center, Ankara, TurkeyAcıbadem University Ankara Hospital, Department of Urology, Ankara, TurkeyUniversity of Health Sciences, Gulhane Training and Research Hospital, Department of Urology, Ankara, TurkeyUniversity of Health Sciences, Gulhane Training and Research Hospital, Department of Urology, Ankara, TurkeyZile State Hospital, Department of Urology, Tokat, TurkeyGazi University School of Medicine, Department of Radiology, Ankara, TurkeyAcibadem University, Ankara Hospital, Department of Radiology, Ankara, TurkeyGazi University School of Medicine, Department of Urology, Ankara, TurkeyObjective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and compare with current literature. Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men were retrospectively analyzed. PI-RADS scores were determined as 3, 4 and 5 in 222 (62%), 107 (29.8%) and 29 (8.1%) patients, respectively. Totally 454 lesions were underwent MRI-US FPBx. 303 (66.7%) lesions were scored as PI-RADS 3, 120 (26.4%) lesions were scored as PI-RADS 4 and 31 (6.8%) lesions were scored as PI-RADS 5. 315 (69.3%) of lesions were in peripheral zone, 26 (5.7%) were in central zone, 111 (24.4%) were in transitional zone and 2 of them were in anterior fibromuscular stroma. Results: Overall prostate cancer detection rate was 36.3%. Concerning detection rates, MRI-US FPBx alone and transrectal ultrasonography guided prostate biopsy (TRUS-Bx) alone were 27.6% and 26.5%, respectively. Cancer detection rate only through MRI-US FPBx PIRADS-3 and PI-RADS 4&5 were 6.9% and 20.6%, respectively. Clinically significant prostate cancer (csPCa) rates were evaluated and csPCa to overall prostate cancer (PCa) rates for TRUS-Bx, MRI-US FPBx and combined techniques were 16.8%, 35.4% and 39.2%, respectively. Results of 11 patients were evaluated as benign. Conclusion: MRI-US FPBx significantly increases success rate of prostate biopsy procedure. Regarding current MRI technology, it is not appropriate to consider MRI-US FPBx as a stand-alone biopsy option without concomitant with TRUS-Bx.https://dergipark.org.tr/tr/download/article-file/1479046prostate cancerbiopsymrifusion |
| spellingShingle | Sercan Yilmaz Halil Cagri Aybal Hakan Ozdemir Eymen Gazel Engin Kaya Serdar Yalcin Mehmet Yilmaz Ali Yusuf Oner Mehmet Yorubulut Lutfi Tunc Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients Yeni Üroloji Dergisi prostate cancer biopsy mri fusion |
| title | Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| title_full | Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| title_fullStr | Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| title_full_unstemmed | Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| title_short | Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| title_sort | single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients |
| topic | prostate cancer biopsy mri fusion |
| url | https://dergipark.org.tr/tr/download/article-file/1479046 |
| work_keys_str_mv | AT sercanyilmaz singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT halilcagriaybal singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT hakanozdemir singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT eymengazel singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT enginkaya singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT serdaryalcin singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT mehmetyilmaz singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT aliyusufoner singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT mehmetyorubulut singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients AT lutfitunc singlecenterresultsofmagneticresonanceimagingultrasoundguidedfusionprostatebiopsyobtainedpatients |